南方财经全媒体记者 李依农上海报道

In an exclusive interview with SFC, Dr. Pavol Dobrocky, the President and CEO of Boehringer Ingelheim Greater China, offers his perspective on the significant transformations and opportunities resulting from China's policies of reform and opening-up. 

Dr. Pavol Dobrocky stated, Boehringer Ingelheim entered the Chinese market  in 1994, and witnessed the tremendous changes China has gone through in the past three to four decades. These transformations encompass the robust growth of the Chinese economy and the immense opportunity to deliver innovative pharmaceuticals to a vast population of patients in China.  

策划：于晓娜   

监制：施诗

责任编辑：徐旭 和佳

记者：朱萍 林昀肖 李依农

拍摄：林昀肖

剪辑：李群 实习生 许晓彤

设计：林军明

新媒体统筹：丁青云 曾婷芳 赖禧 黄达迅

海外运营监制: 黄燕淑

海外运营内容统筹: 黄子豪

海外运营编辑：庄欢 吴婉婕 龙李华 张伟韬

出品：南方财经全媒体集团